Normal report of liquid-based cytology

Liquid-based cytology testing uses a liquid-based analytical cell detection network to detect cervical cells and perform cell classification diagnosis. It is currently one of the more advanced cervical cytology testing technologies in the world and the most direct and simple method for cervical cancer screening. It is economical, safe, minimally invasive, easy to operate, and can screen out cervical precancerous lesions before the patient shows clinical symptoms.

The epithelial tissue of the cervix is ​​composed of the squamous epithelial tissue inside the vagina of the cervix and the columnar epithelial tissue of the endocervical canal. The part where the two epithelial tissues meet is called the squamocolumnar junction, which is a very prone location for cervical cancer. Liquid-based cytology testing uses a specially made sampling brush to obtain the fallen cells at this location, and then uses the test instrument to produce it, and then perform Pap staining to observe the shape of the cells to determine and evaluate whether there are currently cervical lesions, as well as the degree of lesions.

The inspection report is then sent out using the TBS reporting system, which includes

First, the evaluation of specimen collection quality, that is, the specimen collection satisfaction rate, which is divided into satisfactory specimen collection and unsatisfactory specimen collection;

Second, microbial infection, including fungal infection, trichomonas infection, viral infection, mycoplasma infection, etc.;

Third, reactive cellular changes, including inflammatory cellular changes and contractile reactive cellular changes;

Fourth, atypical squamous epithelial cells, including squamous epithelial cells that cannot be diagnosed and atypical squamous epithelial cells that tend to have high-ratio squamous intraepithelial degeneration;

Fifth, squamous intraepithelial neoplasia, including mild squamous intraepithelial neoplasia and high-aspect squamous intraepithelial neoplasia;

Sixth, squamous cell carcinoma;

Seventh, atypical glandular cells, including atypical glandular cells that cannot be diagnosed and atypical glandular epithelial cells that tend to be tumorous;

Eighth, adenocarcinoma and its malignant tumors.

Based on the above judgment results, in order to establish and appropriate diagnosis methods, effective communication with clinical physicians can be carried out. Clinicians may choose the corresponding treatment plan based on the cervical liquid-based cytology examination report.

Liquid-based cytology normal report

If the cervical liquid-based cytology test report shows no cervical intraepithelial neoplasia and no inflammatory space-occupying lesions, it means everything is normal and there is no need to worry. In addition, there is also a report of atypical squamous epithelial hyperplasia. This situation requires further examination and a test for human papillomavirus infection. If the human papillomavirus test is normal, it can be observed temporarily and cervical cancer screening can be done after half a year to a year. If the liquid-based cytology test report shows a low-grade disease, it should be combined with the results of the HPV test. If the HPV is high-risk and positive, the next step is to do a colposcopy. If it is an advanced disease, a colposcopy must be performed immediately, and a puncture biopsy should be performed under the observation of the colposcopy, and the next step of treatment should be determined based on the pathological results.